NCT06889987View on ClinicalTrials.gov

Bilateral Ultrasound Guided Intramuscular Quadratus Lumborum Plane Block Versus Bilateral Lateral Quadratus Lumborum Plane Block in Controlling Postoperative Pain in Cancer Patients Undergoing Open Nephrectomy

NARecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

December 10, 2024

Primary Completion Date

December 6, 2025

Study Completion Date

December 6, 2025

Conditions
BilateralUltrasoundIntramuscular Quadratus Lumborum Plane BlockLateral Quadratus Lumborum Plane BlockPostoperative PainCancer PatientsOpen Nephrectomy
Interventions
DRUG

Intramuscular quadratus lumborum block

Patients will receive bilateral ultrasound-guided intramuscular quadratus lumborum block with an injection of 0.4 ml/kg bupivacaine 0.25% after induction of general anesthesia

DRUG

Lateral quadratus lumborum block

Patients will receive bilateral ultrasound-guided lateral quadratus lumborum with an injection of 0.4 ml/kg of bupivacaine 0.25 after induction of general anesthesia.

DRUG

General anesthesia

Patients will receive only general anesthesia without any block.

Trial Locations (1)

11796

RECRUITING

National Cancer Institute, Cairo

All Listed Sponsors
lead

National Cancer Institute, Egypt

OTHER